# Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels

> **NCT03747523** · EARLY_PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 44 (actual)

## Conditions studied

- Ergocalciferol

## Interventions

- **DRUG:** Ergocalciferol

## Key facts

- **NCT ID:** NCT03747523
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-12
- **Primary completion:** 2019-12-20
- **Final completion:** 2020-01-27
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03747523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03747523, "Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03747523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*